Harel Insurance Investments & Financial Services’s Evogene EVGN Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio EVGN Stock Details EVGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,500	Closed	-$139K	–	739
2020 Q3	$139K	Buy	+3,500	New	+$62.5K	﹤0.01%	355
2019 Q2	–	Sell	-7,950	Closed	-$145K	–	485
2019 Q1	$145K	Hold	7,950	–	–	0.01%	157
2018 Q4	$157K	Hold	7,950	–	–	0.01%	197
2018 Q3	$247K	Hold	7,950	–	–	0.01%	187
2018 Q2	$227K	Hold	7,950	–	–	0.01%	178
2018 Q1	$252K	Sell	7,950 -5,857	-42%	-$218K	0.01%	190
2017 Q4	$424K	Buy	+13,807	New	+$542K	0.03%	146

Other funds holding EVGN

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

PDT Partners New York $1.69B AUM 74.01% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return

Harel Insurance Investments & Financial Services's EVGN Position: Q4 2020 in Review

Harel Insurance Investments & Financial Services sold out of Evogene (EVGN) in Q4 2020, closing a stake of 3,500 shares — an estimated $139K sold.

Harel Insurance Investments & Financial Services first reported a position in EVGN in Q4 2017 and held it in 7 quarters. The position peaked at $424K in Q4 2017. 33 funds tracked by Wall St. Rank hold EVGN as of Q4 2020.

Harel Insurance Investments & Financial Services reported no remaining Evogene position as of Q4 2020 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 3,500 Evogene shares in Q4 2020, an estimated $139K.
Harel Insurance Investments & Financial Services first reported a position in Evogene in Q4 2017 and held it in 7 quarters.
Harel Insurance Investments & Financial Services's Evogene position peaked at $424K in Q4 2017.
33 funds tracked by Wall St. Rank held Evogene as of Q4 2020.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q4 2020, filed 26 Jan 2021.